Tetanus is a severe, often fatal infectious disease affecting horses caused by the toxin produced by the bacterium Clostridium tetani. This gram-positive, spore-forming anaerobic organism is ubiquitous in the environment, particularly in soil contaminated with manure, making horses highly susceptible to infection through wounds. The potent neurotoxin tetanospasmin, produced by vegetative C. tetani bacteria in infected wounds, travels via peripheral nerves to the central nervous system where it blocks inhibitory neurotransmission. This results in the characteristic sustained muscle rigidity and violent spasms that give tetanus its common name, lockjaw, referring to the rigid clenching of the jaw muscles that is often an early sign of the disease.
Horses are considered the most susceptible of all domestic animals to tetanus, requiring only minimal amounts of toxin to produce clinical disease. The condition occurs worldwide wherever horses are kept, with higher prevalence in areas of intensive horse farming where environmental contamination with C. tetani spores is greatest. Before widespread vaccination, tetanus was a common and devastating disease in horse populations. While modern vaccination programs have dramatically reduced incidence in well-managed horses, tetanus remains a significant threat to unvaccinated individuals, those with lapsed vaccination status, and foals before maternal antibodies wane. The disease continues to claim lives despite being entirely preventable through vaccination.
The impact of tetanus on equine health is profound, with mortality rates historically ranging from 50% to 80% even with intensive treatment. The progressive muscle rigidity affects all skeletal muscles, eventually compromising respiratory function as the muscles of respiration become involved. Affected horses experience tremendous suffering from sustained muscle contractions, inability to eat or drink normally, and the distressing nature of full-body spasms triggered by minimal stimulation. Secondary complications including aspiration pneumonia, fractures from violent spasms, and pressure sores from recumbency add to the disease burden. Survivors of tetanus may recover completely but face a prolonged and intensive rehabilitation period.
Treatability of tetanus depends on early recognition, aggressive intervention, and excellent supportive care, but even with optimal treatment, many cases prove fatal. Treatment aims to neutralize circulating toxin before it binds to nerve tissue, eliminate the source of toxin production, control muscle spasms, and provide supportive care while the nervous system recovers. The tetanospasmin toxin binds irreversibly to nerve tissue, meaning that bound toxin cannot be neutralized and recovery requires regeneration of affected neural connections over weeks. This lengthy recovery process makes intensive nursing care essential for the duration. Vaccination remains by far the most effective approach to this disease, preventing infection entirely rather than attempting to treat established disease.
